Efficacy and safety of Tuina therapy for children with combined allergic rhinitis and asthma syndrome in remission: a randomized controlled trial protocol - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effectiveness and Safety of Tuina Therapy in Pediatric Patients with Remission of Combined Allergic Rhinitis and Asthma Syndrome: A Protocol for a Randomized Controlled Trial

  • By

  • Xin Yun Chia

  • Junhao Cai

  • Dan Dai

  • Qing Ji

  • Shijian Liu

  • Wenyi Wang

  • Mengran Si

  • Yan Yang

  • Ping Lu

  • Xiaoqiu Wang

  • Sijie Dang

  • Yi Zhong

  • Shuxia Wang

  • Guimao Wang

  • Bin Xiao

  • June 23, 2026

Share

Original Source(s)

Efficacy and safety of Tuina therapy for children with combined allergic rhinitis and asthma syndrome in remission: a randomized controlled trial protocol

  • by Xin Yun Chia, Junhao Cai, Dan Dai, Qing Ji, Shijian Liu, Wenyi Wang, Mengran Si, Yan Yang, Ping Lu, Xiaoqiu Wang, Sijie Dang, Yi Zhong, Shuxia Wang, Guimao Wang, Bin Xiao

  • June 23, 2026

Related Content

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

Three-dimensional reconstruction by a computer-assisted surgery system for pediatric hydronephrosis caused by accessory renal artery compression: a single-center retrospective observational comparative case series